Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Low serum ferritin levels are linked to hair loss in women.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The IRF2BP2 gene affects sheep fleece quality by influencing fiber traits.

Telogen effluvium causes sudden hair loss, often due to stress or changes, and is treated by addressing the cause and offering support.

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Tofacitinib helped a woman regrow hair with no major side effects.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

TEDAR is crucial for skin cell differentiation and barrier formation.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

GV-350 improves hair growth and quality of life in iron-deficient women without side effects.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Almond and sunflower seed tofu is high in protein and marketed for diets and vegetarians.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

The LTF gene may help predict and manage nonspecific orbital inflammation.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

The gene Tfap2b is essential for creating a type of stem cell in zebrafish that can become different pigment cells.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

The method effectively detects MeT and TP in dried blood spots after cream application.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.